Erythema Multiforme Due to 5% Imiquimod Cream
Eritema multiforme por imiquimod 5% crema
Read
6408
Timeswas read the article
3195
Total PDF
3213
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 53 | 35 | 88 |
| 2025 5 | 92 | 33 | 125 |
| 2025 4 | 94 | 31 | 125 |
| 2025 3 | 89 | 23 | 112 |
| 2025 2 | 81 | 25 | 106 |
| 2025 1 | 54 | 24 | 78 |
| 2024 12 | 69 | 22 | 91 |
| 2024 11 | 65 | 50 | 115 |
| 2024 10 | 51 | 40 | 91 |
| 2024 9 | 54 | 32 | 86 |
| 2024 8 | 69 | 49 | 118 |
| 2024 7 | 47 | 43 | 90 |
| 2024 6 | 50 | 39 | 89 |
| 2024 5 | 56 | 25 | 81 |
| 2024 4 | 51 | 29 | 80 |
| 2024 3 | 43 | 46 | 89 |
| 2024 2 | 36 | 36 | 72 |
| 2024 1 | 42 | 42 | 84 |
| 2023 12 | 27 | 23 | 50 |
| 2023 11 | 34 | 43 | 77 |
| 2023 10 | 34 | 34 | 68 |
| 2023 9 | 35 | 26 | 61 |
| 2023 8 | 29 | 37 | 66 |
| 2023 7 | 26 | 45 | 71 |
| 2023 6 | 29 | 24 | 53 |
| 2023 5 | 37 | 35 | 72 |
| 2023 4 | 18 | 31 | 49 |
| 2023 3 | 18 | 42 | 60 |
| 2023 2 | 20 | 38 | 58 |
| 2023 1 | 20 | 44 | 64 |
| 2022 12 | 23 | 41 | 64 |
| 2022 11 | 12 | 33 | 45 |
| 2022 10 | 15 | 37 | 52 |
| 2022 9 | 21 | 35 | 56 |
| 2022 8 | 17 | 44 | 61 |
| 2022 7 | 19 | 42 | 61 |
| 2022 6 | 17 | 24 | 41 |
| 2022 5 | 22 | 38 | 60 |
| 2022 4 | 22 | 42 | 64 |
| 2022 3 | 14 | 56 | 70 |
| 2022 2 | 21 | 29 | 50 |
| 2022 1 | 20 | 37 | 57 |
| 2021 12 | 11 | 43 | 54 |
| 2021 11 | 22 | 40 | 62 |
| 2021 10 | 28 | 39 | 67 |
| 2021 9 | 22 | 36 | 58 |
| 2021 8 | 21 | 33 | 54 |
| 2021 7 | 19 | 29 | 48 |
| 2021 6 | 16 | 34 | 50 |
| 2021 5 | 23 | 32 | 55 |
| 2021 4 | 31 | 45 | 76 |
| 2021 3 | 45 | 33 | 78 |
| 2021 2 | 42 | 45 | 87 |
| 2021 1 | 24 | 27 | 51 |
| 2020 12 | 12 | 28 | 40 |
| 2020 11 | 18 | 25 | 43 |
| 2020 10 | 25 | 17 | 42 |
| 2020 9 | 17 | 9 | 26 |
| 2020 8 | 14 | 34 | 48 |
| 2020 7 | 7 | 22 | 29 |
| 2020 6 | 16 | 27 | 43 |
| 2020 5 | 15 | 27 | 42 |
| 2020 4 | 15 | 35 | 50 |
| 2020 3 | 17 | 46 | 63 |
| 2020 2 | 1 | 26 | 27 |
| 2020 1 | 0 | 11 | 11 |
| 2019 12 | 0 | 18 | 18 |
| 2019 11 | 0 | 3 | 3 |
| 2019 10 | 0 | 6 | 6 |
| 2019 9 | 0 | 4 | 4 |
| 2019 8 | 0 | 16 | 16 |
| 2019 7 | 0 | 20 | 20 |
| 2019 6 | 0 | 9 | 9 |
| 2019 5 | 0 | 48 | 48 |
| 2019 4 | 0 | 18 | 18 |
| 2019 3 | 0 | 11 | 11 |
| 2019 2 | 0 | 7 | 7 |
| 2019 1 | 0 | 4 | 4 |
| 2018 10 | 1 | 0 | 1 |
| 2018 2 | 7 | 2 | 9 |
| 2018 1 | 10 | 2 | 12 |
| 2017 12 | 12 | 9 | 21 |
| 2017 11 | 3 | 0 | 3 |
| 2017 10 | 10 | 4 | 14 |
| 2017 9 | 13 | 7 | 20 |
| 2017 8 | 10 | 5 | 15 |
| 2017 7 | 7 | 4 | 11 |
| 2017 6 | 12 | 7 | 19 |
| 2017 5 | 11 | 7 | 18 |
| 2017 4 | 12 | 17 | 29 |
| 2017 3 | 11 | 41 | 52 |
| 2017 2 | 9 | 14 | 23 |
| 2017 1 | 9 | 7 | 16 |
| 2016 12 | 11 | 17 | 28 |
| 2016 11 | 17 | 16 | 33 |
| 2016 10 | 7 | 11 | 18 |
| 2016 9 | 15 | 5 | 20 |
| 2016 8 | 14 | 2 | 16 |
| 2016 7 | 18 | 9 | 27 |
| 2016 6 | 16 | 12 | 28 |
| 2016 5 | 5 | 9 | 14 |
| 2016 4 | 6 | 0 | 6 |
| 2016 3 | 4 | 0 | 4 |
| 2016 2 | 5 | 1 | 6 |
| 2016 1 | 3 | 2 | 5 |
| 2015 12 | 6 | 1 | 7 |
| 2015 11 | 12 | 1 | 13 |
| 2015 10 | 6 | 2 | 8 |
| 2015 9 | 8 | 2 | 10 |
| 2015 8 | 5 | 4 | 9 |
| 2015 7 | 22 | 7 | 29 |
| 2015 6 | 24 | 7 | 31 |
| 2015 5 | 42 | 25 | 67 |
| 2015 4 | 22 | 17 | 39 |
| 2015 3 | 25 | 19 | 44 |
| 2015 2 | 23 | 19 | 42 |
| 2015 1 | 22 | 19 | 41 |
| 2014 12 | 20 | 13 | 33 |
| 2014 11 | 21 | 23 | 44 |
| 2014 10 | 32 | 23 | 55 |
| 2014 9 | 19 | 19 | 38 |
| 2014 8 | 33 | 21 | 54 |
| 2014 7 | 36 | 26 | 62 |
| 2014 6 | 41 | 25 | 66 |
| 2014 5 | 51 | 33 | 84 |
| 2014 4 | 38 | 16 | 54 |
| 2014 3 | 32 | 28 | 60 |
| 2014 2 | 16 | 22 | 38 |
| 2014 1 | 31 | 15 | 46 |
| 2013 12 | 33 | 7 | 40 |
| 2013 11 | 34 | 17 | 51 |
| 2013 10 | 23 | 17 | 40 |
| 2013 9 | 25 | 18 | 43 |
| 2013 8 | 26 | 18 | 44 |
| 2013 7 | 27 | 30 | 57 |
| 2013 6 | 16 | 14 | 30 |
| 2013 5 | 23 | 18 | 41 |
| 2013 4 | 26 | 25 | 51 |
| 2013 3 | 21 | 17 | 38 |
| 2013 2 | 7 | 6 | 13 |
Show all
